MAPT and Alzheimer disease: However, based on the most recent research framework criteria, AD is a progressive neurodegenerative disease that involves neuropathological changes such as the accumulation of Amyloid (A) and Tau (T) as well as Neurodegeneration (N), which begin years to decades before any cognitive symptoms of clinical AD become apparent (1).